Targets specific to certain Treg cell types in the TME of pancreatic cancer

Authors

  • Yi Chen

DOI:

https://doi.org/10.54097/3q9z2y25

Keywords:

Pancreatic cancer; Treg; immunosuppression; Antitumor property; Specific target.

Abstract

The increased content of Treg cells in the pancreatic cancer TME shows the development of pancreatic cancer is largely influenced by treg cells. Regulatory T cells (Treg) have a powerful immune suppression function, under normal circumstances, have the function of maintaining autoimmune tolerance. When Treg cells expressing abnormally in tumor tissue, they can inhibit normal anti-tumor immune response, accelerate the immune escape in tumor cells, promote tumor growth. Meanwhile, Treg can also inhibit tumor growth through anti-inflammatory and anti-angiogenesis routes. Blind killing and inhibition of Treg will destroy the maintenance of the body's self-immune tolerance and cause some damage. In this paper, the duality of Treg cells is summarized through two aspects, including the summary analysis of specific targets on different types of Treg cells in TME to find the targets that can specifically kill immunosuppressive Treg cells; discuss the interactions between Treg cells and their surrounding cells, and their relationship with the duality of Treg cells, in order to provide the basis for reducing damage and optimizing immunotherapy during immunotherapy.

Downloads

Download data is not yet available.

References

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022, 72:7-33.

Bilotta MT, Antignani A, Fitzgerald DJ. Managing the TME to improve the efficacy of cancer therapy. Front Immunol 2022, 13:954992.

Shan F, Somasundaram A, Bruno TC, Workman CJ, Vignali DAA. Therapeutic targeting of regulatory T cells in cancer. Trends Cancer 2022, 8:944-961.

Zhang Y, Yan W, Mathew E, et al. CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice. Cancer Immunol Res 2014, 2:423-435.

Zhang Y, Lazarus J, Steele NG, et al. Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis. Cancer Discov 2020, 10:422-439.

Xu L, Lu Y, Deng Z, et al. Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma. J Transl Med 2022, 20:210.

Shevyrev D, Tereshchenko V. Treg Heterogeneity, Function, and Homeostasis. Front Immunol 2019, 10:3100.

Feuerer M, Hill JA, Mathis D, et al. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 2009, 10:689-695.

Nishikawa H, Koyama S. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. J Immunother Cancer 2021, 9.

Aykut B, Chen R, Miller G. Regulatory T Cells Keep Pancreatic Cancer at Bay. Cancer Discov 2020, 10:345-347.

Downloads

Published

29-12-2023